GLP-1 receptor agonists in patients on antipsychotic medications?

There is a lot of excitement about the advent of glucagon-like peptide 1 (GLP-1) receptor agonists in medicine—for the management of diabetes mellitus, obesity, and overweight with at least one weight-related comorbid condition. For other articles on this website about GLP-1 receptor agonists, please see Related Pages below. Have GLP-1 receptor agonists been studied for…